| SCENIC: single-cell regulatory network inference and clustering S Aibar, CB González-Blas, T Moerman, VA Huynh-Thu, H Imrichova, ... Nature methods 14 (11), 1083-1086, 2017 | 5717 | 2017 |
| Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair S Cortellino, J Xu, M Sannai, R Moore, E Caretti, A Cigliano, M Le Coz, ... Cell 146 (1), 67-79, 2011 | 1049 | 2011 |
| Toward minimal residual disease-directed therapy in melanoma F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ... Cell 174 (4), 843-855. e19, 2018 | 809 | 2018 |
| Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state A Verfaillie, H Imrichova, ZK Atak, M Dewaele, F Rambow, G Hulselmans, ... Nature communications 6 (1), 6683, 2015 | 499 | 2015 |
| Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities F Rambow, JC Marine, CR Goding Genes & development 33 (19-20), 1295-1318, 2019 | 363 | 2019 |
| Codon-specific translation reprogramming promotes resistance to targeted therapy F Rapino, S Delaunay, F Rambow, Z Zhou, L Tharun, P De Tullio, O Sin, ... Nature 558 (7711), 605-609, 2018 | 284 | 2018 |
| CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours B Kruse, AC Buzzai, N Shridhar, AD Braun, S Gellert, K Knauth, J Pozniak, ... Nature 618 (7967), 1033-1040, 2023 | 276 | 2023 |
| Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma J Wouters, Z Kalender-Atak, L Minnoye, KI Spanier, M De Waegeneer, ... Nature cell biology 22 (8), 986-998, 2020 | 259 | 2020 |
| A cellular hierarchy in melanoma uncouples growth and metastasis P Karras, I Bordeu, J Pozniak, A Nowosad, C Pazzi, N Van Raemdonck, ... Nature 610 (7930), 190-198, 2022 | 230 | 2022 |
| Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth M Dewaele, T Tabaglio, K Willekens, M Bezzi, SX Teo, DHP Low, CM Koh, ... The Journal of clinical investigation 126 (1), 68-84, 2016 | 202 | 2016 |
| Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia CC Bell, KA Fennell, YC Chan, F Rambow, MM Yeung, D Vassiliadis, ... Nature communications 10 (1), 2723, 2019 | 199 | 2019 |
| P-Rex1 is required for efficient melanoblast migration and melanoma metastasis CR Lindsay, S Lawn, AD Campbell, WJ Faller, F Rambow, RL Mort, ... Nature communications 2 (1), 555, 2011 | 199 | 2011 |
| A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression II Verginadis, H Avgousti, J Monslow, G Skoufos, F Chinga, K Kim, ... Nature cell biology 24 (6), 940-953, 2022 | 163 | 2022 |
| A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma J Pozniak, D Pedri, E Landeloos, Y Van Herck, A Antoranz, ... Cell 187 (1), 166-183. e25, 2024 | 159 | 2024 |
| Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop Y Hua, G Vella, F Rambow, E Allen, AA Martinez, M Duhamel, A Takeda, ... Cancer cell 40 (12), 1600-1618. e10, 2022 | 156 | 2022 |
| Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy A Talebi, J Dehairs, F Rambow, A Rogiers, D Nittner, R Derua, ... Nature communications 9 (1), 2500, 2018 | 152 | 2018 |
| Mouse cutaneous melanoma induced by mutant BRaf arises from expansion and dedifferentiation of mature pigmented melanocytes C Köhler, D Nittner, F Rambow, E Radaelli, F Stanchi, N Vandamme, ... Cell stem cell 21 (5), 679-693. e6, 2017 | 146 | 2017 |
| Epithelial‐to‐mesenchymal‐like transition events in melanoma D Pedri, P Karras, E Landeloos, JC Marine, F Rambow The FEBS journal 289 (5), 1352-1368, 2022 | 144 | 2022 |
| Chromatin-bound MDM2 regulates serine metabolism and redox homeostasis independently of p53 R Riscal, E Schrepfer, G Arena, MY Cissé, F Bellvert, M Heuillet, ... Molecular cell 62 (6), 890-902, 2016 | 142 | 2016 |
| Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma O Marin-Bejar, A Rogiers, M Dewaele, J Femel, P Karras, J Pozniak, ... Cancer cell 39 (8), 1135-1149. e8, 2021 | 141 | 2021 |
